Status:

TERMINATED

Functional Characteristic Properties of Skeletal Muscle Tissue Assessed by P31 Spectroscopy in Young and Older Adults

Lead Sponsor:

University Hospital, Toulouse

Conditions:

Sarcopenia

Eligibility:

MALE

25-99 years

Phase:

NA

Brief Summary

P31 nuclear magnetic resonance (RMN) Spectroscopy (SRM P31) has currently being poorly used in the field of sarcopenia. The aim of the CAMUS study is to investigate the feasibility a protocol of SRM ...

Eligibility Criteria

Inclusion

  • Old group : 70+ years males
  • Young group : 25 to 30 years males
  • Sedentary males in the 2 groups
  • Informed consent

Exclusion

  • Contraindication to perform a RMN

Key Trial Info

Start Date :

April 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2017

Estimated Enrollment :

1 Patients enrolled

Trial Details

Trial ID

NCT03336294

Start Date

April 1 2013

End Date

December 31 2017

Last Update

July 16 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital Toulouse

Toulouse, France, 31300